Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 31 to 45 of 110 results for anticoagulation

  1. Anticoagulation and antiplatelet therapy: In adults with biological valve replacement, what effect does anticoagulation or antiplatelet therapy have on long-term valve function and outcomes?

    Question Anticoagulation and antiplatelet therapy: In adults with biological valve replacement, what effect does...

    Research recommendation
    Published
    16 December 2021

  2. Improving patients time in range on warfarin

    aimed to safely manage patients according to NICE guidelines regarding anticoagulation. Patients on warfarin need tight control over...

    Shared learning
    Last updated
    10 May 2021

  3. Atrial Fibrillation (AF) Holistic Care Pathway

    practice were chosen and incorporated locally. Examples include: Anticoagulation assessment with better uptake of DOAC. Address...

    Shared learning
    Last updated
    4 March 2022

  4. Implementing point-of-care D-dimer tests for deep vein thrombosis (DVT)

    states that if a D-dimer test cannot be obtained within 4 hours, interim anticoagulation should be given. If a person has a low...

    Shared learning
    Last updated
    2 December 2020

  5. Improving the care of patients discharged following a pulmonary embolism, in line with NICE Guidelines (NG158)

    about 2–8% in the 3 months following diagnosis. The benefit of early anticoagulation to improve mortality and decrease recurrent...

    Shared learning
    Published
    1 July 2021

  6. Acute upper gastrointestinal bleeding in over 16s: management (CG141)

    This guideline covers how upper gastrointestinal bleeding can be effectively managed in adults and young people aged 16 years and older. It aims to identify which diagnostic and therapeutic steps are useful so hospitals can develop a structure in which clinical teams can deliver an optimum service for people who develop this condition.

    Clinical guideline
    Last updated
    25 August 2016
    View recommendations

    Sections for CG141

  7. Insights from the NHS: the adoption of self-monitoring coagulation status using point-of-care coagulometers (the CoaguChek XS system and the INRatio2 PT/INR monitor) for atrial fibrillation and heart valve disease

    Health Call INR service, was developed by the clinicians working in the anticoagulation clinic and the chief pharmacist. This ensured...

    Shared learning
    Last updated
    5 July 2016

  8. Apixaban for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation (TA275)

    Evidence-based recommendations on apixaban (Eliquis) for preventing stroke and systemic embolism in adults with non-valvular atrial fibrillation.

    Technology appraisal guidance
    Last updated
    2 July 2021
    View recommendations

    Sections for TA275

  9. Safe and effective management of stroke prevention in atrial fibrillation

    comprises of anticoagulants, with clear evidence to support the fact that anticoagulation with vitamin K antagonists (VKAs) or direct...

    Shared learning
    Last updated
    10 May 2021

  10. GreenLight XPS for treating benign prostatic hyperplasia (MTG74)

    Evidence-based recommendations on GreenLight XPS for benign prostatic hyperplasia.

    Medical technologies guidance
    Published
    29 November 2022
    View recommendations

    Sections for MTG74

  11. Aortic valve reconstruction with processed bovine pericardium (IPG604)

    Evidence-based recommendations on aortic valve reconstruction with processed bovine pericardium. This involves replacing a damaged aortic valve with a new valve made from chemically treated cow pericardium.

    Interventional procedures guidance
    Published
    14 February 2018
    View recommendations

    Sections for IPG604

  12. Accelerated Implantable Cardiac Monitor (ICM) insertion for the detection of Atrial Fibrillation in Cryptogenic Stroke

    performed remotely by the cardiac physiology team. If AF was detected, anticoagulation therapy was initiated without delay by the nurse...

    Shared learning
    Published
    4 May 2021

  13. What is the most clinical and cost-effective strategy, as identified by a consensus survey, for the perioperative management of anticoagulation treatment in people taking a vitamin K antagonist with a target international normalised ratio (INR) of more than 3 who need bridging therapy?

    identified by a consensus survey, for the perioperative management of anticoagulation treatment in people taking a vitamin K antagonist...

    Research recommendation
    Published
    26 October 2020

  14. Reducing the risk of stroke in AF: using the NICE PDA with patients not currently treated with anticoagulants

    Some practices initiated anticoagulation themselves, but others referred their patients to the secondary care...

    Shared learning
    Last updated
    5 July 2021

  15. Various modes used to reinforce NICE guidance for venous thrombo-embolism prophylaxis

    technology services' helped publish a screen saver based reminder about the anticoagulation policy recommendations on all networked...

    Shared learning
    Last updated
    24 April 2015